RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

RBC Capital analyst Arun Viswanathan maintained a Buy rating on Chemours Company (CC – Research Report) on January 16 and set a price target of ...

Morgan Stanley analyst Christopher Snyder maintained a Hold rating on Otis Worldwide (OTIS – Research Report) today and set a price target of ...

Currently, no analysts following Palantir have set a target price above its recent close of $79.89, according to FactSet data ...

The bank, which has been under review by the Texas attorney general over its involvement in the Net-Zero Banking Alliance, ...

courtesy of RBC Capital Markets' Rishi Jaluria. Palantir stock, which jumped 6% on Friday, slid 5% on Monday. Morgan Stanley's Singh acknowledges that the Alex Karp-led company has gotten a lot of ...

Morgan Stanley (NYSE:MS), a leading global financial services firm with a substantial market capitalization of $220.72 billion, has been navigating a complex financial landscape with resilience and ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital ... the optimism that has prevailed in the markets since late 2022, the above average ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...

The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.